Pampusch, M. S., Abdelaal, H. M., Cartwright, E. K., Molden, J. S., Davey, B. C., Sauve, J. D., Sevcik, E. N., Rendahl, A. K., Rakasz, E. G., Connick, E., Berger, E. A. and Skinner, P. J. CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection. PLOS Pathogens. 2022; 18(2), e1009831. doi: 10.1371/journal.ppat.1009831